I have similar thoughts about the approval process, though much less coherent.
From a citizen (non-medical education) level of knowledge, I wonder how we should go about reaching a decision regarding getting a jab.
Though I am obliged to say, where I and my SO currently live (Lithuania and Russia) it will soon become not a “whether”, but “which” in a month due to regulations.
I think that COVID-19 is bad enough, that even with the risks as described I still got a shot of the BionTech vaccine three weeks ago.
If there’s a real free choice I think the answer is currently Novavaxx as it’s the classic adjuvant + antigen combination. Evidence suggests that it has less average side-effects and it doesn’t get your body to kill it’s own cells. Not getting your body to kill it’s own cells means that certain immune responses are not triggered but the trials we have shows Novavaxx to have comparable effectiveness to the other vaccines.
Thank you for detailed comments!
I have similar thoughts about the approval process, though much less coherent.
From a citizen (non-medical education) level of knowledge, I wonder how we should go about reaching a decision regarding getting a jab.
Though I am obliged to say, where I and my SO currently live (Lithuania and Russia) it will soon become not a “whether”, but “which” in a month due to regulations.
I think that COVID-19 is bad enough, that even with the risks as described I still got a shot of the BionTech vaccine three weeks ago.
If there’s a real free choice I think the answer is currently Novavaxx as it’s the classic adjuvant + antigen combination. Evidence suggests that it has less average side-effects and it doesn’t get your body to kill it’s own cells. Not getting your body to kill it’s own cells means that certain immune responses are not triggered but the trials we have shows Novavaxx to have comparable effectiveness to the other vaccines.
Interesting information, thanks. However, the choice is as follows (numbers indicate available units):
1. Moderna (4990)
2. Comirnaty (Pfizer) (25111)
3. Vaxzevria (AstraZeneca) (6073)
4. Janssen (3611)
The viral vector technology has previously been used for Ebola, right? What do we know about that?
UPD: apparently, we might get Novavax sometime soon. I might want to wait for that.